Viral inactivation is an important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses.
The Major Drivers for the Viral Inactivation Market are rapid growth in pharmaceutical and biotechnology industries and a strong trend of R&D investments in the life sciences industry. An increasing number of new drug launches, rise in chronic disease burden, and increasing government support for the pharmaceutical and biotechnology industries will also aid the growth of this Viral Inactivation Market
Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics
Research Methodology Adopted for Viral Inactivation Market:
A combination of bottom-up and top-down approaches was used to calculate market sizes and growth rates of the global market and its subsegments.
Secondary information was used to identify overall revenue, geographic reach, and product portfolios of Viral Inactivation Market players. Estimates of their viral inactivation market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates
Global Viral Inactivation Market Based On;
· Geography and more
Global Viral Inactivation Market Major Segmentation in Detail;
The product segments included in the report are kits and reagents, services, and viral inactivation systems and accessories.
Based on end-user this Viral Inactivation Market is categorized into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users. Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.
Major Players in The Viral Inactivation Market:
Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi PharmaTech (Cayman) Inc. (China).
The Geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). The North America segment is further divided into Canada and the U.S. Asia segment is further divided into China, Japan, India, and Rest of Asia.
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly